DOCSLIB.ORG
Explore
Sign Up
Log In
Upload
Search
Home
» Tags
» Tenocyclidine
Tenocyclidine
Control Substance List
Advisory Council on the Misuse of Drugs Chair: Professor Les Iversen Secretary: Rachel Fowler 3Rd Floor Seacole Building 2
Designer Drugs: a Review
Alcohol and Drug Abuse Subchapter 9 Regulated Drug Rule 1.0 Authority
UNODC Correction(14Th March 2006).Qxd
Development and Validation of Two Innovative Quantitative Liquid
Phencyclidine Analogues (“PCP-Like”)
Special M: the Evolution of the Recreational Use of Ketamine and Methoxetamine
Summary of 2020 Legislation
Poisons Standard February 2020
December 2018.PUB
(12) United States Patent (10) Patent No.: US 8,974,365 B2 Best (45) Date of Patent: Mar
New Psychoactive Substances. a Challenge to Public Health
Tenocyclidine Treatment in Soman-Poisoned Rats — Intriguing Results on Genotoxicity Versus Protection
View the PDF Document
From PCP to MXE: a Comprehensive Review of the Non-Medical Use of Dissociative Drugs Hamilton Morrisa and Jason Wallachb*
Findings and Recommendations of the Task Force to Prevent Deaths from Unintentional Drug Overdoses in North Carolina, 2003
(12) Patent Application Publication (10) Pub. No.: US 2006/0127486A1 Moerck Et Al
Top View
List of Scheduling Actions, Controlled Substances And
Critical Review of KETAMINE
( 12 ) Patent Application Publication ( 10 ) Pub . No .: US 2020/0215078 A1
June 2021 Brief
IFU PCP Phencyclidine Monlabtest Strip English
Polycyclic Compounds: Ideal Drug Scaffolds for the Design of Multiple Mechanism Drugs?
WO 2014/018563 A2 30 January 2014 (30.01.2014)
S01 Subjective and Physiological Effects Following Controlled Smoked, Vaporized, and Oral Cannabis Administrations to Frequent and Occasional Cannabis Smokers
Ketamine: a Review of Use and Harm
Cannabis and Cannabis and 5 Hallucinogens 5 Hallucinogens
G Proteinactivation
Flwsffiffi Thutr0tri*Rhtnilsf Rutgts'
Drugs of Abuse, a DEA Resource Guide (2020 Edition)
The Non-Medical Use of Prescription Drugs Policy Direction Issues
Ketamine Critical Review Report
Drug Scheduling
M100907, a Selective 5-HT2A Receptor Antagonist and a Potential Antipsychotic Drug, Facilitates N-Methyl-D-Aspartate-Receptor Me
Evaluating and Expanding Knowledge and Awareness of Health
Drugs of Abuse (2017 Edition)
Case Reports of the Clinical Features and Acute Management of Two Novel Designer Drugs
On the Resilience of the Dark Net Market Ecosystem to Law Enforcement Intervention
Ketamine Update Review Report